Xin Yao

Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Xinan Sheng, Xieqiao Yan, Lin Wang et al. · Clinical Cancer Research · 2020 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials

Xinan Sheng, Lin Wang, Zhisong He et al. · Journal of Clinical Oncology · 2023 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Two Distinct Types of Blood Vessels in Clear Cell Renal Cell Carcinoma Have Contrasting Prognostic Implications

Xin Yao, Chao-Nan Qian, Zhong-Fa Zhang et al. · Clinical Cancer Research · 2007 · 99 citations · Full text

Medicine, Oncology, Surgery +17

Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer

Hui Qin, Yijiang Ni, Jichun Tong et al. · Medical Oncology · 2014 · 67 citations

Medicine, Cancer Biology, Oncology +10

Safety, Efficacy, and Biomarker Analysis of Toripalimab in Patients with Previously Treated Advanced Urothelial Carcinoma: Results from a Multicenter Phase II Trial POLARIS-03

Xinan Sheng, Haige Chen, Bin Hu et al. · Clinical Cancer Research · 2021 · 67 citations · Full text

Medicine, Oncology, Pharmacotherapy +17